| Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment X Chen, C Glytsou, H Zhou, S Narang, DE Reyna, A Lopez, ... Cancer discovery 9 (7), 890-909, 2019 | 243 | 2019 |
| TET1 is a tumor suppressor of hematopoietic malignancy L Cimmino, MM Dawlaty, D Ndiaye-Lobry, YS Yap, S Bakogianni, Y Yu, ... Nature immunology 16 (6), 653-662, 2015 | 232 | 2015 |
| Extensive changes in DNA methylation are associated with expression of mutant huntingtin CW Ng, F Yildirim, YS Yap, S Dalin, BJ Matthews, PJ Velez, A Labadorf, ... Proceedings of the National Academy of Sciences 110 (6), 2354-2359, 2013 | 191 | 2013 |
| Analysis of in vitro insulin-resistance models and their physiological relevance to in vivo diet-induced adipose insulin resistance KA Lo, A Labadorf, NJ Kennedy, MS Han, YS Yap, B Matthews, X Xin, ... Cell reports 5 (1), 259-270, 2013 | 124 | 2013 |
| pH-Sensitive brush polymer-drug conjugates by ring-opening metathesis copolymerization J Zou, G Jafr, E Themistou, Y Yap, ZAP Wintrob, P Alexandridis, ... Chemical Communications 47 (15), 4493-4495, 2011 | 107 | 2011 |
| Elucidating MicroRNA regulatory networks using transcriptional, post-transcriptional, and histone modification measurements SJC Gosline, AM Gurtan, CK JnBaptiste, A Bosson, P Milani, S Dalin, ... Cell reports 14 (2), 310-319, 2016 | 102 | 2016 |
| Hepatic dysfunction caused by consumption of a high-fat diet AR Soltis, NJ Kennedy, X Xin, F Zhou, SB Ficarro, YS Yap, BJ Matthews, ... Cell reports 21 (11), 3317-3328, 2017 | 78 | 2017 |
| Enterococcus faecalis enhances cell proliferation through hydrogen peroxide-mediated epidermal growth factor receptor activation K Boonanantanasarn, AL Gill, YS Yap, V Jayaprakash, MA Sullivan, ... Infection and immunity 80 (10), 3545-3558, 2012 | 58 | 2012 |
| Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia JP Brabson, T Leesang, YS Yap, J Wang, MQ Lam, B Fang, I Dolgalev, ... Cell reports 42 (1), 2023 | 7 | 2023 |
| Erratum: TET1 is a tumor suppressor of hematopoietic malignancy L Cimmino, MM Dawlaty, D Ndiaye-Lobry, YS Yap, S Bakogianni, Y Yu, ... Nature immunology 16 (8), 889-889, 2015 | 6 | 2015 |
| Synthesis, characterization, and biomedical assessment of pH-sensitive brush polymer-drug conjugates J Zou, G Jafr, E Themistou, Y Yap, P Alexandridis, AC Ceacareanu, ... Abstracts of Papers of the American Chemical Society, 181-POLY, 2010 | 2 | 2010 |
| Vitamin C enhances PARPi efficacy for the treatment of AML JP Brabson, T Leesang, B Fang, J Wang, V Strippoli, YS Yap, ... Blood 138, 1168, 2021 | 1 | 2021 |
| Abstract A050: MDSC-derived transmembrane TNF is a central regulator of stromal inflammation and T-cell dysfunction in pancreatic cancer AM Adams, H Amirian, CI Rafie, K Rajkumar, E Dickey, HM Marsh, ... Cancer Research 84 (17_Supplement_2), A050-A050, 2024 | | 2024 |
| Retinoic Acid and Ascorbate Remodel the Epigenome of Leukemia Cells to Improve Therapeutic Efficacy By Enhancing TET Activity T Leesang, YS Yap, JP Brabson, A Klimas, EL Ahearn, DA Barbieri, ... Blood 142 (Supplement 1), 5706-5706, 2023 | | 2023 |
| 3112–RETINOIC ACID AND ASCORBATE REMODEL THE EPIGENOME OF LEUKEMIA CELLS TO IMPROVE THERAPEUTIC EFFICACY BY ENHANCING TET ACTIVITY T Leesang, YS Yap, J Brabson, F Beckedorff, L Cimmino Experimental Hematology 124, S106, 2023 | | 2023 |
| 3039–OXIDIZED 5-METHYLCYTOSINE MODULATES SYNTHETIC LETHALITY TO POLY-ADP-RIBOSE POLYMERASE INHIBITORS IN ACUTE MYELOID LEUKEMIA J Brabson, T Leesang, J Wang, B Fang, YS Yap, I Dolgalev, D Barbieri, ... Experimental Hematology 111, S64, 2022 | | 2022 |
| Abstract B2-45: Uncovering coordinated regulation of transcription factors by microRNAs using integrated network models SJC Gosline, AM Gurtan, CK JnBaptiste, A Bosson, P Milani, S Dalin, ... Cancer Research 75 (22_Supplement_2), B2-45-B2-45, 2015 | | 2015 |
| Synthesis of double-brush copolymers by tandem RAFT polymerization, ROP, and ROMP Y Li, E Themistou, J Zou, YS Yap, C Cheng Abstracts of Papers of the American Chemical Society, 464-POLY, 2010 | | 2010 |
Bryan J MatthewsCAMP4 Therapeutics在 bu.edu 的电子邮件经过验证
